Sandip Agarwala - Net Worth and Insider Trading
Sandip Agarwala Net Worth
The estimated net worth of Sandip Agarwala is at least $876,052 dollars as of 2024-09-20. Sandip Agarwala is the Director, 10% Owner of Talaris Therapeutics Inc and owns about 322,078 shares of Talaris Therapeutics Inc (TALS) stock worth over $876,052. Details can be seen in Sandip Agarwala's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sandip Agarwala has not made any transactions after 2021-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sandip Agarwala
Sandip Agarwala Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sandip Agarwala owns 1 companies in total, including Talaris Therapeutics Inc (TALS) .
Click here to see the complete history of Sandip Agarwala’s form 4 insider trades.
Insider Ownership Summary of Sandip Agarwala
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TALS | Talaris Therapeutics Inc | 2021-05-11 | director & 10 percent owner |
Sandip Agarwala Latest Holdings Summary
Sandip Agarwala currently owns a total of 1 stock. Sandip Agarwala owns 322,078 shares of Talaris Therapeutics Inc (TALS) as of May 11, 2021, with a value of $876,052.
Latest Holdings of Sandip Agarwala
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TALS | Talaris Therapeutics Inc | 2021-05-11 | 322,078 | 2.72 | 876,052 |
Holding Weightings of Sandip Agarwala
Sandip Agarwala Form 4 Trading Tracker
According to the SEC Form 4 filings, Sandip Agarwala has made a total of 1 transactions in Talaris Therapeutics Inc (TALS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Talaris Therapeutics Inc is the acquisition of 23,500 shares on May 11, 2021, which cost Sandip Agarwala around $4 Million.
Insider Trading History of Sandip Agarwala
- 1
Sandip Agarwala Trading Performance
GuruFocus tracks the stock performance after each of Sandip Agarwala's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sandip Agarwala is -0.35%. GuruFocus also compares Sandip Agarwala's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sandip Agarwala within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sandip Agarwala's insider trading performs compared to the benchmark.
Performance of Sandip Agarwala
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.29 | | | | | |
| Relative Return to S&P 500(%) | 20.99 | | | | | |
Sandip Agarwala Ownership Network
Sandip Agarwala Owned Company Details
What does Talaris Therapeutics Inc do?
Who are the key executives at Talaris Therapeutics Inc?
Sandip Agarwala is the director & 10 percent owner of Talaris Therapeutics Inc. Other key executives at Talaris Therapeutics Inc include Interim CFO Ryan F. Robinson , Chief Medical Officer Yung H. Chyung , and CBO & GC and Secretary W Bradford Middlekauff .
Talaris Therapeutics Inc (TALS) Insider Trades Summary
Over the past 18 months, Sandip Agarwala made no insider transaction in Talaris Therapeutics Inc (TALS). Other recent insider transactions involving Talaris Therapeutics Inc (TALS) include a net sale of 451,201 shares made by Suzanne Ildstad ,
In summary, during the past 3 months, insiders sold 0 shares of Talaris Therapeutics Inc (TALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,120 shares of Talaris Therapeutics Inc (TALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,120 shares.
Talaris Therapeutics Inc (TALS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Talaris Therapeutics Inc Insider Transactions
Sandip Agarwala Mailing Address
Above is the net worth, insider trading, and ownership report for Sandip Agarwala. You might contact Sandip Agarwala via mailing address: C/o Longitude Capital Management, Llc, 2740 Sand Hill Road, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
